Cargando…
Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer
INTRODUCTION: Serum profiling using proteomic techniques has great potential to detect biomarkers that might improve diagnosis and predict outcome for breast cancer patients (BC). This study used surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry (MS) to identi...
Autores principales: | Chung, Liping, Moore, Katrina, Phillips, Leo, Boyle, Frances M, Marsh, Deborah J, Baxter, Robert C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095593/ https://www.ncbi.nlm.nih.gov/pubmed/24935269 http://dx.doi.org/10.1186/bcr3676 |
Ejemplares similares
-
Novel Prognostic Markers in Triple-Negative Breast Cancer Discovered by MALDI-Mass Spectrometry Imaging
por: Phillips, Leo, et al.
Publicado: (2019) -
Serum Biomarkers Identification by Mass Spectrometry in High-Mortality Tumors
por: Tessitore, Alessandra, et al.
Publicado: (2013) -
Screening and identification of serum biomarkers of osteoarticular tuberculosis based on mass spectrometry
por: Chen, Ximeng, et al.
Publicado: (2020) -
Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry
por: Luque-Garcia, Jose L., et al.
Publicado: (2007) -
Mass spectrometry-based proteomics identify novel serum osteoarthritis biomarkers
por: Tardif, Ginette, et al.
Publicado: (2022)